Arnold J M, McDevitt D G
Br J Clin Pharmacol. 1984 Sep;18(3):311-6. doi: 10.1111/j.1365-2125.1984.tb02469.x.
Eight healthy normal subjects (19-23 years) received graded intravenous isoprenaline infusions PRE- and POST-atropine, 0.04 mg/kg i.v. The adequacy of atropinization was tested with bolus intravenous injections of phenylephrine. PRE-atropine, isoprenaline caused an increase in heart rate and systolic pressure, but a decrease in diastolic pressure with little change in mean pressure (+32.8 +/- 3.0 beats/min, +18.9 +/- 3.0 mm Hg, -13.5 +/- 1.9 mm Hg, -2.7 +/- 1.9 mg Hg respectively at isoprenaline 2 micrograms/min). POST-atropine, the increase in heart rate was enhanced, the rise in systolic pressure abolished and the falls in diastolic and mean pressures exaggerated (+47.0 +/- 2.8 beats/min, -8.9 +/- 2.9 mm Hg, -27.3 +/- 2.1 mm Hg, -21.1 +/- 1.9 mm Hg, respectively at isoprenaline 2 micrograms/min). During an isoprenaline infusion, when the heart rate and blood pressure changes are stable, there is an increase rather than a decrease in cardiac vagal tone.
八名健康正常受试者(19 - 23岁)在静脉注射0.04 mg/kg阿托品前后接受了静脉注射异丙肾上腺素的分级输注。通过静脉推注去氧肾上腺素来测试阿托品化是否充分。注射阿托品前,异丙肾上腺素使心率和收缩压升高,但舒张压降低,平均压变化不大(异丙肾上腺素2微克/分钟时分别为+32.8±3.0次/分钟、+18.9±3.0毫米汞柱、-13.5±1.9毫米汞柱、-2.7±1.9毫米汞柱)。注射阿托品后,心率升高增强,收缩压升高消失,舒张压和平均压下降加剧(异丙肾上腺素2微克/分钟时分别为+47.0±2.8次/分钟、-8.9±2.9毫米汞柱、-27.3±2.1毫米汞柱、-21.1±1.9毫米汞柱)。在输注异丙肾上腺素期间,当心率和血压变化稳定时,心脏迷走神经张力增加而非降低。